Skip to main content
Quest Diagnostics

Tick-borne Illness: A Panel Discussion About Emerging Diagnostic Insights - 2021

Description: A panel discussion about tick-borne illnesses: emerging diagnostic insights, presented by Dr Hema Kapoor, Dr Meghan Starolis, Dr Tara Givens, and Dr Robert Jones; moderated by Dr Ann Salm

 

Learning objectives:

 - Differentiate the best-use cases for PCR vs serology testing

 - Understand the clinical application of newly launched tick-borne tests

 - Determine the clinical implications of CPVID-19 on tick-borne illness, diagnosis, and prevalence

 

Date:
Jun 18, 2021
Presenter(s):
Tara Givens, PhD
Robert Jones, DO, MS, FACP, FIDSA, CPE
Hema Kapoor, MD, SM, D(ABMM)
Meghan Starolis
Moderator(s):
Ann Salm, M (ASCP)CM, MS, PhD

Related content

Publication
Utility and recommendations for the use of multiplex molecular gastrointestinal pathogen panels
Publication
A Comparison of Lyme Serological Testing Platforms with a Panel of Clinically Characterized Samples from Various Stages of Lyme Disease
On-Demand Webinar
Tick-borne Illness A Panel Discussion About Emerging Diagnostics Insights
Test FAQ
Lyme Disease Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.